Interpretation of Gamma Index for Quality Assurance of Simultaneously Integrated Boost (SIB) IMRT Plans for Head and Neck Carcinoma

[1] Kouloulias V, Antypas C, Liakouli Z, et al. The first implementation of IMRT technique for head & neck and prostate cancer patients in public sector in Greece: feasibility, treatment planning and dose delivery verification using the delta (4PT) Pre-Treatment volumetric quality assurance system. J BUON. 2014;20(1):196-205.Search in Google Scholar

[2] Roxby KJ, Crosbie JC. Pre-treatment verification of intensity modulated radiation therapy plans using a commercial electronic portal dosimetry system. Australas Phys Eng Sci Med. 2010;33(1):51-57.10.1007/s13246-010-0001-0Open DOISearch in Google Scholar

[3] Franceschini D, Paiar F, Meattini I, et al. Simultaneous integrated boost–intensity-modulated radiotherapy in head and neck cancer. Laryngoscope. 2013;123(12):E97-103.10.1002/lary.24257Search in Google Scholar

[4] Mohan R, Wu Q, Manning M, Schmidt-Ullrich R. Radiobiological considerations in the design of fractionation strategies for intensity-modulated radiation therapy of head and neck cancers. Int J Radiat Oncol Biol Phys. 2000;46(3):619-630.10.1016/S0360-3016(99)00438-1Open DOISearch in Google Scholar

[5] Krishnan J, Rao S, Hegde S, Shetty J. A Dosimetric Comparison of Double Arc Volumetric Modulated Arc Therapy with Large Field Intensity Modulated Radiation Therapy for Head and Neck Cancer. IJMPCERO. 2015;4(4):353-363.10.4236/ijmpcero.2015.44042Search in Google Scholar

[6] Suzuki M, Nakamatsu K, Kanamori S, et al. Feasibility study of the simultaneous integrated boost (SIB) method for malignant gliomas using intensity-modulated radiotherapy (IMRT). Jpn J Clin Oncol. 2003;33(6):271-277.10.1093/jjco/hyg053Open DOISearch in Google Scholar

[7] Elawady RA, Attalla EM, Elshemey WM, et al. Dose verification of intensity modulated radiotherapy in head and neck tumors. Int J Cancer Ther Oncol. 2014;2(3):02037.10.14319/ijcto.0203.7Open DOISearch in Google Scholar

[8] Agazaryan N, Solberg TD, DeMarco JJ. Patient specific quality assurance for the delivery of intensity modulated radiotherapy. J Appl Clin Med Phys. 2003;4(1):40-50.10.1120/jacmp.v4i1.2540Search in Google Scholar

[9] Depuydt T, Van Esch A, Huyskens DP. A quantitative evaluation of IMRT dose distributions: refinement and clinical assessment of the gamma evaluation. Radiother Oncol. 2002;62(3):309-319.10.1016/S0167-8140(01)00497-2Open DOISearch in Google Scholar

[10] Low DA, Dempsey JF. Evaluation of the gamma dose distribution comparison method. Med Phys. 2003;30(9):2455-2464.10.1118/1.159871114528967Search in Google Scholar

[11] Mijheer B, Georg D. Guidelines for the verification of IMRT. Brussels, Belgium: ESTRO; 2008.Search in Google Scholar

[12] Ezzell GA, Burmeister JW, Dogan N, et al. IMRT commissioning: multiple institution planning and dosimetry comparisons, a report from AAPM Task Group 119. Med Phys. 2009;36(11):5359-5373.10.1118/1.323810419994544Search in Google Scholar

[13] Tonigan JR. Evaluation of intensity modulated radiation therapy (IMRT) delivery error due to IMRT treatment plan complexity and improperly matched dosimetry data. MSc Thesis. The University of Texas. Houston, Texas; 2011.Search in Google Scholar

[14] Varatharaj C, Ravikumar M, Sathiyan S, et al. Dosimetric verification of brain and head and neck intensity-modulated radiation therapy treatment using EDR2 films and 2D ion chamber array matrix. J Cancer Res Ther. 2010;6(2):179-184.10.4103/0973-1482.6523320622365Search in Google Scholar

[15] Stasi M, Bresciani S, Miranti A, et al. Pretreatment patient-specific IMRT quality assurance: A correlation study between gamma index and patient clinical dose volume histogram. Med Phys. 2012;39(12):7626-7634.10.1118/1.476776323231310Search in Google Scholar

[16] Caivano R, Califano G, Fiorentino A, et al. Clinically relevant quality assurance for intensity modulated radiotherapy plans: gamma maps and DVH-based evaluation. Cancer Invest. 2014;32(3):85-91.10.3109/07357907.2013.87747824499109Open DOISearch in Google Scholar

[17] Li H, Dong L, Zhang L, et al. Toward a better understanding of the gamma index: Investigation of parameters with a surface-based distance method. Med Phys. 2011;38(12):6730-6741.10.1118/1.3659707329856522149855Search in Google Scholar

[18] Molineu A, Followill DS, Balter PA, et al. Design and implementation of an anthropomorphic quality assurance phantom for intensity-modulated radiation therapy for the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys. 2005;63(2):577-583.10.1016/j.ijrobp.2005.05.02116168849Open DOISearch in Google Scholar

[19] Grégoire V, Mackie TR. State of the art on dose prescription, reporting and recording in Intensity-Modulated Radiation Therapy (ICRU report No. 83). Cancer Radiother. 2011;15(6-7):555-559.10.1016/j.canrad.2011.04.00321802333Open DOISearch in Google Scholar

[20] Chaikh A, Desgranges C, Balosso J. Statistical methods to evaluate the correlation between measured and calculated dose using quality assurance method in IMRT. Int J Cancer Ther Oncol. 2015;3(4):10.14319/ijcto.34.11Search in Google Scholar

[21] Stock M, Kroupa B, Georg D. Interpretation and evaluation of the γ index and the γ index angle for the verification of IMRT hybrid plans. Phys Med Biol. 2005;50(3):399-411.10.1088/0031-9155/50/3/00115773719Open DOISearch in Google Scholar

[22] Chung JB, Kim JS, Ha SW, Ye SJ. Statistical analysis of IMRT dosimetry quality assurance measurements for local delivery guideline. Radiat Oncol. 2011;6(1):27.10.1186/1748-717X-6-27307387521439096Search in Google Scholar

[23] Howell RM, Smith IP, Jarrio CS. Establishing action levels for EPID-based QA for IMRT. J Appl Clin Med Phys.2008;9(3):16-25.10.1120/jacmp.v9i3.2721572229418716584Open DOISearch in Google Scholar

[24] van Zijtveld M, Dirkx ML, de Boer HC, Heijmen BJ. Dosimetric pre-treatment verification of IMRT using an EPID; clinical experience. Radiother Oncol. 2006;81(2):168-175.10.1016/j.radonc.2006.09.00817055604Open DOISearch in Google Scholar

[25] Childress NL, White RA, Bloch C, et al. Retrospective analysis of 2D patient-specific IMRT verifications. Med Phys. 2005;32(4):838-850.10.1118/1.187927215895566Open DOISearch in Google Scholar

[26] Fraass B, Doppke K, Hunt M, et al. American Association of Physicists in Medicine Radiation Therapy Committee Task Group 53: quality assurance for clinical radiotherapy treatment planning. Med Phys. 1998;25(10):1773-1829.10.1118/1.5983739800687Search in Google Scholar

[27] Jang SY, Liu HH, Mohan R. Underestimation of low-dose radiation in treatment planning of intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2008;71(5):1537-1546.10.1016/j.ijrobp.2008.04.01418513883Search in Google Scholar

[28] Deng J, Pawlicki T, Chen Y, et al. The MLC tongue-and-groove effect on IMRT dose distributions. Phys Med Biol. 2001;46(4):1039-106010.1088/0031-9155/46/4/31011324950Open DOISearch in Google Scholar

[29] Li JS, Lin T, Chen L, et al. Uncertainties in IMRT dosimetry. Med Phys. 2010;37(6):2491-2500.10.1118/1.341399720632560Open DOISearch in Google Scholar

[30] Das IJ, Ding GX, Ahnesjö A. Small fields: nonequilibrium radiation dosimetry. Med Phys. 2008;35(1):206-215.10.1118/1.281535618293576Search in Google Scholar

[31] Ceberg C. A note on the interpretation of the gamma evaluation index. Journal of Physics: Conference Series. 2013;(444)1:012082.10.1088/1742-6596/444/1/012082Search in Google Scholar